We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.96B
AUM Growth
+$565M
Cap. Flow
-$238M
Cap. Flow %
-2.66%
Top 10 Hldgs %
14.1%
Holding
748
New
26
Increased
189
Reduced
394
Closed
36

Top Buys

Rank Stock Value
1
STAG icon
STAG Industrial
STAG
+$26.5M
2
CRI icon
Carter's
CRI
+$23.3M
3
HWC icon
Hancock Whitney
HWC
+$19.5M
4
UL icon
Unilever
UL
+$16.7M
5
MTDR icon
Matador Resources
MTDR
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.98%
2 Industrials 16.66%
3 Technology 16.47%
4 Financials 13.37%
5 Consumer Discretionary 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMW
426
DELISTED
VMware, Inc
VMW
$1.85M 0.02%
15,070
NVDA icon
427
NVIDIA
NVDA
$5.09T
$1.85M 0.02%
126,430
-55,440
-30% -$813K
CVS icon
428
CVS Health
CVS
$133B
$1.79M 0.02%
19,243
+40
+0.2% +$3.86K
ECON icon
429
Columbia Emerging Markets Consumer ETF
ECON
$338M
$1.77M 0.02%
89,770
-188
-0.2% -$3.61K
SCHA icon
430
Schwab U.S Small- Cap ETF
SCHA
$23.2B
$1.74M 0.02%
85,674
-2
-0% -$41
YUM icon
431
Yum! Brands
YUM
$40.8B
$1.73M 0.02%
13,518
-36
-0.3% -$4.36K
EW icon
432
Edwards Lifesciences
EW
$51.3B
$1.72M 0.02%
23,117
-300
-1% -$23.1K
DUK icon
433
Duke Energy
DUK
$96.7B
$1.72M 0.02%
16,690
+45
+0.3% +$4.32K
ETN icon
434
Eaton
ETN
$171B
$1.72M 0.02%
10,946
-24
-0.2% -$3.68K
TROW icon
435
T. Rowe Price
TROW
$24.1B
$1.67M 0.02%
15,348
-125
-0.8% -$14.1K
BAX icon
436
Baxter International
BAX
$14.3B
$1.67M 0.02%
32,761
-30,689
-48% -$1.65M
FATE icon
437
Fate Therapeutics
FATE
$307M
$1.66M 0.02%
164,235
+11,184
+7% +$210K
NGMS
438
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$1.62M 0.02%
132,608
-61,420
-32% -$925K
ULTA icon
439
Ulta Beauty
ULTA
$23.4B
$1.6M 0.02%
3,422
-26,261
-88% -$11.3M
IJH icon
440
iShares Core S&P Mid-Cap ETF
IJH
$126B
$1.55M 0.02%
32,095
-80
-0.2% -$3.87K
QCOM icon
441
Qualcomm
QCOM
$170B
$1.53M 0.02%
13,964
-940
-6% -$110K
KLAC icon
442
KLA
KLAC
$255B
$1.52M 0.02%
40,300
-29,830
-43% -$1.04M
HAS icon
443
Hasbro
HAS
$12.8B
$1.48M 0.02%
24,325
-1,289
-5% -$80.5K
SLYV icon
444
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.06B
$1.47M 0.02%
19,748
T icon
445
AT&T
T
$159B
$1.46M 0.02%
79,192
-5,570
-7% -$99.7K
LIN icon
446
Linde
LIN
$224B
$1.45M 0.02%
4,448
-218
-5% -$68.3K
VEU icon
447
Vanguard FTSE All-World ex-US ETF
VEU
$67.9B
$1.45M 0.02%
28,938
-1,361
-4% -$66K
EEM icon
448
iShares MSCI Emerging Markets ETF
EEM
$29.6B
$1.43M 0.02%
37,818
-13,457
-26% -$497K
STWD icon
449
Starwood Property Trust
STWD
$5.97B
$1.42M 0.02%
77,500
CSX icon
450
CSX Corp
CSX
$93.5B
$1.41M 0.02%
45,563
-1,564
-3% -$47K

Similar funds

Segall Bryant & Hamill's Q4 2022 Portfolio in Review

As of Q4 2022, Segall Bryant & Hamill held 748 positions worth $8.96B, up 6.7% from $8.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Segall Bryant & Hamill's Q4 2022 filing shows 26 new, 189 increased, 394 reduced and 36 closed positions. Its largest new stake was STAG Industrial: 847,354 shares worth $27.4M. The largest sale was CATALENT, INC., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

  • Segall Bryant & Hamill's largest Q4 2022 buy was STAG Industrial: 847,354 shares worth $27.4M.
  • Segall Bryant & Hamill added most to Hancock Whitney in Q4 2022, an estimated $19.5M increase.
  • Segall Bryant & Hamill's biggest Q4 2022 reduction was CATALENT, INC., cutting an estimated $32.8M.
  • Segall Bryant & Hamill fully exited Avalara, Inc. in Q4 2022, selling an estimated $10.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 14% of its $8.96B portfolio in Q4 2022.
  • Segall Bryant & Hamill opened 26 new positions and closed 36 in Q4 2022.
  • Segall Bryant & Hamill's portfolio value rose 6.7% quarter-over-quarter to $8.96B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2022, filed 14 Feb 2023.